Skip to main content

Table 2 Univariate and multivariate analyses for OS in training cohort

From: Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma

Variable Univariate analysis Multivariate analysis
p Hazard ratio 95%confidence interval p Hazard ratio 95%confidence interval
Age (years)(≥60 versus < 60) 0.066 0.380 0.136–1.065    
Gender (female versus male) 0.783 0.865 0.308–2.431    
HBsAg (yes versus no) 0.184 2.621 0.633–10.850    
Cirrhosis (yes versus no) 0.652 1.153 0.621–2.140    
Tumor size(> 5 versus ≤5) 0.002 2.664 1.424–4.983   
Tumor number (multiple versus single) 0.087 1.726 0.924–3.223    
AFP(≥400 versus < 400) 0.007 2.310 1.253–4.258 0.001 2.782 1.496–5.173
Vascular invasion (yes versus no) 0.007 2.327 1.261–4.293   
Child-Pugh grade (B versus A) 0.351 0.389 0.053–2.828    
BCLC Stage(B + C versus 0 + A) 0.010 2.543 1.248–5.181   
Differentiation (poor versus well/moderate) 0.285 1.666 0.653–4.247    
PT (≥13.7 versus < 13.7) 0.094 0.578 0.304–1.099    
ALT (≥ 34 versus < 34) 0.037 2.082 1.046–4.146   
TB (≥12.5 versus < 12.5) 0.230 0.688 0.373–1.268    
GGT (≥49 versus < 49) 0.001 3.825 1.697–8.626 0.001 3.852 1.690–8.782
ALB (≥39.0 versus < 39.0) 0.201 1.548 0.792–3.028    
MPV (≥11.2 versus < 11.2) 0.424 1.300 0.684–2.470    
co NLR-PDW < 0.001 3.342 1.960–5.699 < 0.001 3.721 2.150–6.440
  1. Notes: AFP alpha fetoprotein, BCLC Barcelona Clinic Liver Cancer, PT prothrombin time, ALT Alanine transaminase, TB total bilirubin, GGT gamma-glutamyl transpeptidase, ALB albumin, MPV mean platelet volume, coNLR-PDW combination of NLR and PDW, OS overall survival